Apax to buy Israeli aesthetic device firm Syneron for $397 mln

TEL AVIV, April 3 (Reuters) - British private equity firm Apax Partners has agreed to buy Israel's Syneron Medical Ltd, a non-surgical aesthetic device company, for $11.00 per share in cash, or a total of $397 million, the companies said on Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.